Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
暂无分享,去创建一个
C. Bokemeyer | W. Fiedler | D. Wichmann | S. Kluge | W. Alsdorf | P. Karagiannis | K. Weisel | V. Fuhrmann | Lena Sänger
[1] M. Slavin,et al. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting , 2020, BMC Infectious Diseases.
[2] A. Shimabukuro-Vornhagen,et al. [Hematological-oncological intensive care patients : Treatment without borders]. , 2019, Medizinische Klinik, Intensivmedizin und Notfallmedizin.
[3] M. Gardam,et al. Patient‐ and hospital‐level predictors of vancomycin‐resistant Enterococcus (VRE) bacteremia in Ontario, Canada , 2018, American journal of infection control.
[4] W. Sperr,et al. Consensus statement for cancer patients requiring intensive care support , 2018, Annals of Hematology.
[5] N. Hanna,et al. High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] H. Goldschmidt,et al. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Wujtewicz,et al. The effectiveness of the APACHE II, SAPS II and SOFA prognostic scoring systems in patients with haematological malignancies in the intensive care unit. , 2014, Anaesthesiology intensive therapy.
[8] S. Chevret,et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] S. Chevret,et al. Outcomes in Critically Ill Cancer Patients With Septic Shock of Pulmonary Origin , 2013, Shock.
[10] N. D. de Keizer,et al. Outcomes of cancer patients after unplanned admission to general intensive care units , 2012, Acta oncologica.
[11] R. Boots,et al. Intensive care unit experience of haemopoietic stem cell transplant patients , 2012, Internal medicine journal.
[12] A. Moreau,et al. Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis , 2011, Intensive Care Medicine.
[13] S. Pastores,et al. Intensive care of the cancer patient: recent achievements and remaining challenges , 2011, Annals of intensive care.
[14] K. Laczika,et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience , 2011, Haematologica.
[15] N. Schmitz,et al. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] M. Ostermann,et al. ICU and 6-month outcome of oncology patients in the intensive care unit. , 2010, QJM : monthly journal of the Association of Physicians.
[17] J. M. Teles,et al. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study* , 2010, Critical care medicine.
[18] U. Mellqvist,et al. OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL-AMYLOIDOSIS IN SWEDEN in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 95, issue , pp 393-393 , 2010 .
[19] S. Lapinsky,et al. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit , 2009, Bone Marrow Transplantation.
[20] J. Ledermann,et al. High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] P. Hawkins,et al. Outcome of autologous stem cell transplantation for AL amyloidosis in the UK , 2006, British journal of haematology.
[22] M. Tan,et al. High‐dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma , 2004, Cancer.
[23] É. Azoulay,et al. Improved survival of critically ill cancer patients with septic shock , 2003, Intensive Care Medicine.
[24] P. Thall,et al. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. , 1998, American journal of respiratory and critical care medicine.
[25] J. Vose,et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow , 1997, Bone Marrow Transplantation.
[26] G. Tricot,et al. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] S. Rosenberg,et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.